Victory Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20K | Sell |
|
|||||
|
2025
Q1 | $9.97K | Buy |
|
|||||
|
2024
Q4 | $15.4K | Sell |
|
|||||
|
2024
Q3 | $69.6K | Sell |
|
|||||
|
2024
Q2 | $76.2K | Buy |
|
|||||
|
2024
Q1 | $75.3K | Sell |
|
|||||
|
2023
Q4 | $49.2K | Buy |
|
|||||
|
2023
Q3 | $28.7K | Buy |
|
|||||
|
2023
Q2 | $46.4K | Sell |
|
|||||
|
2023
Q1 | $50.4K | Buy |
|
|||||
|
2022
Q4 | $39K | Sell |
|
|||||
|
2022
Q3 | $49K | Buy |
|
|||||
|
2022
Q2 | $22K | Sell |
|
|||||
|
2022
Q1 | $21K | Sell |
|
|||||
|
2021
Q4 | $110K | Buy |
|
|||||
|
2021
Q3 | $101K | Buy |
|
|||||
|
2021
Q2 | $49K | Buy |
|
|||||
|
2021
Q1 | $59K | Sell |
|
|||||
|
2020
Q4 | $42K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $210K | Buy |
|
|||||
|
2019
Q4 | $208K | Sell |
|
|||||
|
2019
Q3 | $170K | Buy |
|
|||||
|
2019
Q2 | $9K | Hold |
|
|||||
|
2019
Q1 | $8K | Hold |
|
|||||
|
2018
Q4 | $10K | Sell |
|
|||||
|
2018
Q3 | $19K | Sell |
|
|||||
|
2018
Q2 | $982K | Sell |
|
|||||
|
2018
Q1 | $739K | Buy |
|
|||||
|
2017
Q4 | $15K | Hold |
|
|||||
|
2017
Q3 | $19K | Hold |
|
|||||
|
2017
Q2 | $26K | Buy |
|
|||||
|
2017
Q1 | $22K | Hold |
|
|||||
|
2016
Q4 | $21K | Buy |
|
|||||
|
2016
Q3 | $26K | Buy |
|